161 related articles for article (PubMed ID: 17585318)
1. Phosphorylation profiles of protein kinases in alveolar and embryonal rhabdomyosarcoma.
Cen L; Arnoczky KJ; Hsieh FC; Lin HJ; Qualman SJ; Yu S; Xiang H; Lin J
Mod Pathol; 2007 Sep; 20(9):936-46. PubMed ID: 17585318
[TBL] [Abstract][Full Text] [Related]
2. EGFR-dependent and independent activation of Akt/mTOR cascade in bone and soft tissue tumors.
Dobashi Y; Suzuki S; Sato E; Hamada Y; Yanagawa T; Ooi A
Mod Pathol; 2009 Oct; 22(10):1328-40. PubMed ID: 19648884
[TBL] [Abstract][Full Text] [Related]
3. Anaplastic lymphoma kinase status in rhabdomyosarcomas.
Yoshida A; Shibata T; Wakai S; Ushiku T; Tsuta K; Fukayama M; Makimoto A; Furuta K; Tsuda H
Mod Pathol; 2013 Jun; 26(6):772-81. PubMed ID: 23307059
[TBL] [Abstract][Full Text] [Related]
4. Mirk/Dyrk1b mediates cell survival in rhabdomyosarcomas.
Mercer SE; Ewton DZ; Shah S; Naqvi A; Friedman E
Cancer Res; 2006 May; 66(10):5143-50. PubMed ID: 16707437
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.
van Gaal JC; Roeffen MH; Flucke UE; van der Laak JA; van der Heijden G; de Bont ES; Suurmeijer AJ; Versleijen-Jonkers YM; van der Graaf WT
Eur J Cancer; 2013 Nov; 49(16):3462-70. PubMed ID: 23867124
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I has different effects on myogenin induction and cell cycle progression in human alveolar and embryonal rhabdomyosarcoma cells.
Tsuchiya K; Hosoi H; Misawa-Furihata A; Houghton PJ; Sugimoto T
Int J Oncol; 2007 Jul; 31(1):41-7. PubMed ID: 17549403
[TBL] [Abstract][Full Text] [Related]
7. Expression and genomic status of EGFR and ErbB-2 in alveolar and embryonal rhabdomyosarcoma.
Ganti R; Skapek SX; Zhang J; Fuller CE; Wu J; Billups CA; Breitfeld PP; Dalton JD; Meyer WH; Khoury JD
Mod Pathol; 2006 Sep; 19(9):1213-20. PubMed ID: 16729016
[TBL] [Abstract][Full Text] [Related]
8. Focal adhesion kinase (FAK) phosphorylation is a key regulator of embryonal rhabdomyosarcoma (ERMS) cell viability and migration.
Al-Ghabkari A; Qasrawi DO; Alshehri M; Narendran A
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1461-1469. PubMed ID: 31006845
[TBL] [Abstract][Full Text] [Related]
9. ALK protein expression in rhabdomyosarcomas.
Pillay K; Govender D; Chetty R
Histopathology; 2002 Nov; 41(5):461-7. PubMed ID: 12405914
[TBL] [Abstract][Full Text] [Related]
10. PDK-1/AKT pathway as a novel therapeutic target in rhabdomyosarcoma cells using OSU-03012 compound.
Cen L; Hsieh FC; Lin HJ; Chen CS; Qualman SJ; Lin J
Br J Cancer; 2007 Sep; 97(6):785-91. PubMed ID: 17848913
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease.
Chen S; Nakahara T; Uchi H; Takeuchi S; Takahara M; Kido M; Dugu L; Tu Y; Moroi Y; Furue M
Br J Dermatol; 2009 Aug; 161(2):357-63. PubMed ID: 19438435
[TBL] [Abstract][Full Text] [Related]
12. [Study on activation of AKT/mTOR pathway in anaplastic large cell lymphoma].
Li JF; Li GD; Gu L; Liu WP; Li FY; Liao DY; Ma ZG
Zhonghua Xue Ye Xue Za Zhi; 2008 Oct; 29(10):649-53. PubMed ID: 19176054
[TBL] [Abstract][Full Text] [Related]
13. Phosphotyrosyl proteins in childhood rhabdomyosarcomas: phosphorylation of catenins and components of the insulin-like growth factor type I receptor signaling cascade.
McManus MJ; Hutt PJ; Maihle NJ
J Pediatr Hematol Oncol; 1997; 19(4):319-26. PubMed ID: 9256831
[TBL] [Abstract][Full Text] [Related]
14. Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma.
Ohali A; Avigad S; Naumov I; Goshen Y; Ash S; Yaniv I
Genes Chromosomes Cancer; 2008 Nov; 47(11):965-70. PubMed ID: 18663749
[TBL] [Abstract][Full Text] [Related]
15. Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival.
Petricoin EF; Espina V; Araujo RP; Midura B; Yeung C; Wan X; Eichler GS; Johann DJ; Qualman S; Tsokos M; Krishnan K; Helman LJ; Liotta LA
Cancer Res; 2007 Apr; 67(7):3431-40. PubMed ID: 17409454
[TBL] [Abstract][Full Text] [Related]
16. Evidence of ambiguous differentiation and mTOR pathway dysregulation in subependymal giant cell astrocytoma.
Barrows BD; Rutkowski MJ; Gültekın SH; Parsa AT; Tıhan T
Turk Patoloji Derg; 2012; 28(2):95-103. PubMed ID: 22627626
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin signaling pathway in anaplastic large cell lymphoma.
Gao J; Yin M; Zhu Y; Gu L; Zhang Y; Li Q; Jia C; Ma Z
BMC Cancer; 2013 Oct; 13():471. PubMed ID: 24112608
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma.
Annavarapu SR; Cialfi S; Dominici C; Kokai GK; Uccini S; Ceccarelli S; McDowell HP; Helliwell TR
Lab Invest; 2013 Oct; 93(10):1090-9. PubMed ID: 23999248
[TBL] [Abstract][Full Text] [Related]
19. Cell division cycle control in embryonal and alveolar rhabdomyosarcomas.
Moretti A; Borriello A; Monno F; Criscuolo M; Rosolen A; Esposito G; Dello Iacovo R; Della Ragione F; Iolascon A
Eur J Cancer; 2002 Nov; 38(17):2290-9. PubMed ID: 12441266
[TBL] [Abstract][Full Text] [Related]
20. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma.
Peponi E; Drakos E; Reyes G; Leventaki V; Rassidakis GZ; Medeiros LJ
Am J Pathol; 2006 Dec; 169(6):2171-80. PubMed ID: 17148679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
